Verrica Pharmaceuticals Stock Price on October 28, 2024
| VRCA Stock | USD 1.24 0.13 11.71% |
Below is the normalized historical share price chart for Verrica Pharmaceuticals extending back to June 15, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Verrica Pharmaceuticals stands at 1.24, as last reported on the 28th of November, with the highest price reaching 1.36 and the lowest price hitting 1.13 during the day.
If you're considering investing in Verrica Stock, it is important to understand the factors that can impact its price. Verrica Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0502, which indicates the firm had a -0.0502% return per unit of risk over the last 3 months. Verrica Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Verrica Pharmaceuticals' Coefficient Of Variation of (1,800), risk adjusted performance of (0.03), and Variance of 91.46 to confirm the risk estimate we provide.
At present, Verrica Pharmaceuticals' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 15.1 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 29 M. . At present, Verrica Pharmaceuticals' Price To Sales Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Book Value Ratio is expected to grow to 17.63, whereas Price Earnings Ratio is forecasted to decline to (5.20). Verrica Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 15th of June 2018 | 200 Day MA 4.946 | 50 Day MA 1.3175 | Beta 1.457 |
Verrica |
Sharpe Ratio = -0.0502
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | VRCA |
Estimated Market Risk
| 9.74 actual daily | 86 86% of assets are less volatile |
Expected Return
| -0.49 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Verrica Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Verrica Pharmaceuticals by adding Verrica Pharmaceuticals to a well-diversified portfolio.
Price Book 238.5425 | Enterprise Value Ebitda (11.70) | Price Sales 12.1933 | Shares Float 19.7 M | Wall Street Target Price 6.3333 |
Related Headline
Eton Pharmaceuticals Headline on 28th of October 2024
Eton Pharmaceuticals PT Raised to 15.00 by thelincolnianonline.com
Eton Pharmaceuticals had its price target hoisted by investment analysts at Craig Hallum from 10.00 to 15.00 in a research report issued to clients and investors on Monday, Benzinga reports. The firm currently has a buy rating on the stock. Craig Hallums price target points to a potential upside of
Verrica Pharmaceuticals Valuation on October 28, 2024
It is possible to determine the worth of Verrica Pharmaceuticals on a given historical date. On October 28, 2024 Verrica was worth 1.49 at the beginning of the trading date compared to the closed value of 1.56. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Verrica Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Verrica Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Verrica Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Verrica Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 1.48 | 1.52 | 1.42 | 1.51 | 317,520 | |
10/28/2024 | 1.49 | 1.64 | 1.49 | 1.56 | 430,184 |
| 1.53 | 1.71 | 1.53 | 1.68 | 288,118 |
| Backtest Verrica Pharmaceuticals | | | Verrica Pharmaceuticals History | | | Verrica Pharmaceuticals Valuation | Previous | Next |
Verrica Pharmaceuticals Trading Date Momentum on October 28, 2024
| On October 29 2024 Verrica Pharmaceuticals was traded for 1.68 at the closing time. The top price for the day was 1.71 and the lowest listed price was 1.53 . The trading volume for the day was 288.1 K. The trading history from October 29, 2024 was a factor to the next trading day price jump. The trading price change against the next closing price was 7.69% . The trading price change against the current closing price is 51.92% . |
Verrica Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Verrica Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Verrica Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Verrica financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Verrica Pharmaceuticals Stock history
Verrica Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Verrica is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Verrica Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Verrica Pharmaceuticals stock prices may prove useful in developing a viable investing in Verrica Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 45.3 M | 29 M | |
| Net Loss | -22 M | -23.1 M |
Verrica Pharmaceuticals Quarterly Net Working Capital |
|
Verrica Pharmaceuticals Stock Technical Analysis
Verrica Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Verrica Pharmaceuticals Period Price Range
Low | November 28, 2024
| High |
0.00 | 0.00 |
Verrica Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Verrica Pharmaceuticals November 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Verrica Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Verrica Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Verrica Pharmaceuticals stock market strength indicators, traders can identify Verrica Pharmaceuticals entry and exit signals to maximize returns
Verrica Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Verrica Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Verrica Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Verrica to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.62) | |||
| Total Risk Alpha | (1.98) | |||
| Treynor Ratio | (0.76) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Verrica Stock analysis
When running Verrica Pharmaceuticals' price analysis, check to measure Verrica Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verrica Pharmaceuticals is operating at the current time. Most of Verrica Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Verrica Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verrica Pharmaceuticals' price. Additionally, you may evaluate how the addition of Verrica Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Global Correlations Find global opportunities by holding instruments from different markets |